Abingworth raises $115.3m

View the latest capital raises

Abingworth has raised $115.3 million for its Abingworth Bioventures VII, according to a SEC filing. The London-headquartered firm began fundraising in 2016 with a $400 million target.

Its previous fund raised $225 million in 2014.

The fund will target venture capital opportunities in biotech and healthcare sectors in Europe.